PAVM vs XAIR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 28, 2026

PAVM

38.7
AI Score
VS
XAIR Wins

XAIR

55.3
AI Score

Investment Advisor Scores

PAVM

39score
Recommendation
SELL

XAIR

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PAVM XAIR Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 175.0% 65.5% PAVM
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 38.7/100 55.3/100 XAIR
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD XAIR

Relative Price Performance (Last 90 Days)

PAVM 1M: -21.4% · 3M: -40.4% XAIR 1M: +1030.5% · 3M: +904.4%

Current Technical Phase

PAVM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.5%), weak momentum, RSI 43

RSI (14): 43.3 · Price: $4.95

XAIR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (333.5% over 20 days), RSI 66

RSI (14): 66.2 · Price: $5.28

Fundamentals Snapshot

Metric PAVM XAIR
Market Cap
Forward P/E -2.0 -3.0
Trailing P/E
Revenue (TTM)
Revenue Growth 1.8% 0.7%
Gross Margin -2.3% 0.0%
Operating Margin -365.2% -3.8%
EPS -47.88 -78.89
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XAIR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.